Endocrine oncologists specialize in the diagnosis and treatment of hormone-secreting tumors affecting the endocrine system, including thyroid carcinomas, adrenocortical neoplasms, and neuroendocrine tumors of the pancreas and pituitary. Their expertise combines oncology principles with intricate hormonal regulation, allowing them to assess not only tumor behavior but also endocrine disruptions caused by tumor activity or treatment.
Endocrine oncologists manage complex cases that often involve a multidisciplinary approach, working closely with nuclear medicine, endocrine surgeons, and pathologists to tailor personalized treatment plans. They evaluate the hormonal output of tumors, interpret tumor markers, and oversee therapies such as radioactive iodine, targeted agents, or peptide receptor radionuclide therapy (PRRT). Their role is particularly critical in balancing oncologic treatment with the preservation of endocrine function, mitigating complications like adrenal insufficiency or hypopituitarism. As the prevalence of hormone-related cancers rises, endocrine oncologists continue to refine therapeutic algorithms, ensuring patients benefit from both disease control and endocrine equilibrium.












Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Beyond glucose: A dual mechanism neuroprotective strategy targeting the GPR146 SIRT1 and ADGRG1 MYC axes in alzheimer’s disease
David Petch, utR Biotech
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences
Title : Residual Maladaptation Score (RMS): A novel Risk stratification index for early identification of diabetes risk and valvular heart disease in patients with hypothyroidism beyond standard thyroid markers
Ashwin Karuppan V, Gleneagles Hospitals
Title : Biographical disruption mental health and lived experience in adolescents and young adults with type 1 diabetes
Ariela Orbea Cevallos, Universidad Internacional SEK
Title : Enhancing nutrition therapy on diabetics through increased crop productivity
Grace A Asiko, Apiculture Platform of Kenya